zgc:110179 Antibody

What is zgc:110179 and what is its significance in zebrafish research?

Zgc:110179 refers to a specific zebrafish protein identified through gene cloning projects. Like other zebrafish gene clone (zgc) proteins such as zgc:110339, zgc:110179 represents a protein of interest in developmental biology research . The amino acid sequence structure and protein characteristics determine its molecular function within zebrafish biological systems.

Zebrafish proteins are significant in developmental biology as model systems due to:

• Transparent embryos allowing direct visualization

• Rapid development timeline

• Genetic homology with human proteins

• Accessibility for genetic manipulation

Antibodies against these proteins enable quantification and localization studies across developmental stages, providing insights into protein expression patterns and functional roles.

How are antibodies against zgc:110179 typically generated?

Generation of research-grade antibodies against zebrafish proteins typically follows a rigorous process similar to that used for zgc:110339, involving:

• Sequence analysis and epitope selection from different protein regions (N-terminus, C-terminus, and middle/non-terminus)

• Synthesis of peptide antigens representing these regions

• Immunization protocols in mice to generate monoclonal antibodies

• Screening and selection of antibody-producing hybridoma clones

• Characterization via ELISA to confirm binding specificity and affinity

For research applications, combinations of monoclonal antibodies (mAbs) targeting multiple epitopes are often provided as antibody cocktails to enhance detection sensitivity . These combinations can later be deconvoluted into individual monoclonals if more specific epitope targeting is required.

What are the optimal experimental applications for zgc:110179 antibodies?

Based on the characteristics of similar zebrafish antibodies, zgc:110179 antibodies are suitable for multiple experimental approaches:

ELISA titers for similar antibodies typically reach approximately 10,000, corresponding to detection sensitivity of approximately 1 ng of target protein on Western blots .

What controls are essential when working with zgc:110179 antibodies?

Rigorous experimental design requires multiple controls to ensure specificity and reliability:

• Positive controls:

  • Known samples expressing zgc:110179

  • Recombinant zgc:110179 protein

• Negative controls:

  • Samples known not to express the target (different developmental stages)

  • Secondary antibody-only controls

  • Isotype controls with matched non-specific antibodies

• Validation controls:

  • Peptide competition assays (pre-incubating antibody with immunizing peptide)

  • Knockout/knockdown models where zgc:110179 expression is eliminated

  • Gradient dilution series to establish detection limits

The experimental design should incorporate these controls systematically to distinguish specific signal from background or cross-reactivity.

How can researchers comprehensively validate zgc:110179 antibody specificity?

Antibody validation requires a multi-method approach to ensure experimental reliability:

Recommended Validation Protocol:

• Genetic validation:

  • Testing in CRISPR/Cas9 knockout models

  • Morpholino knockdown with dose-dependent validation

  • Analysis in genetically diverse zebrafish strains

• Biochemical validation:

  • Mass spectrometry identification of immunoprecipitated proteins

  • Western blot analysis for single-band specificity

  • Peptide array screening for epitope mapping

• Orthogonal method correlation:

  • mRNA expression (RT-PCR/RNA-seq) correlation with protein detection

  • Fluorescent protein fusion localization comparison

  • Multiple antibodies targeting different epitopes

Similar to approaches used in validating Zika virus antibodies like ZK2B10, next-generation sequencing can provide detailed analysis of antibody specificity and help identify potential cross-reactivity .

What methodological approaches can overcome challenges in detecting low-abundance zgc:110179?

Detection of low-abundance proteins requires specialized techniques:

• Signal amplification strategies:

  • Tyramide signal amplification (TSA) for immunofluorescence (10-50× signal enhancement)

  • Poly-HRP detection systems for Western blotting

  • Rolling circle amplification for extreme sensitivity requirements

• Sample preparation optimization:

  • Subcellular fractionation to concentrate compartmentalized protein

  • Optimized lysis buffers with appropriate detergents

  • Sample enrichment via immunoprecipitation prior to detection

• Protocol modifications for enhanced sensitivity:

• Advanced detection systems:

  • Near-infrared fluorescent secondary antibodies

  • Quantum dot conjugates for photostable detection

  • Enzyme-labeled fluorescence (ELF) for ultrasensitive detection

These approaches can be particularly valuable when studying proteins with developmental stage-specific or tissue-restricted expression patterns.

What strategies can researchers employ to study zgc:110179 in the context of protein dynamics and interactions?

Understanding protein dynamics requires specialized approaches:

• Temporal expression analysis:

  • Time-course immunoblotting across developmental stages

  • Pulse-chase experiments to determine protein half-life

  • Heat shock inducible systems for controlled expression

• Protein interaction studies:

  • Co-immunoprecipitation with putative interaction partners

  • Proximity ligation assay (PLA) for in situ interaction detection

  • FRET/BRET approaches for direct interaction measurement

  • BioID or APEX proximity labeling for interaction networks

• Post-translational modification analysis:

  • Phospho-specific antibody generation

  • 2D gel electrophoresis for modification-induced mobility shifts

  • Mass spectrometry for comprehensive PTM mapping

• Subcellular trafficking studies:

  • Live imaging with complementary fluorescent protein fusions

  • Photoactivatable or photoconvertible tagging

  • Correlative light and electron microscopy for ultrastructural localization

These approaches can reveal not only where and when zgc:110179 is expressed but also provide insights into its functional roles through its interaction partners and dynamic behavior.

How can researchers design rigorous quantitative experiments using zgc:110179 antibodies?

Quantitative analysis requires careful experimental design and statistical approaches:

• Experimental design considerations:

  • Power analysis to determine appropriate sample sizes

  • Randomized sampling strategies to prevent selection bias

  • Blinded analysis to prevent observer bias

  • Technical and biological replicates to assess variability

• Quantification methods:

  • Standard curve generation using recombinant proteins

  • Internal loading controls appropriate for developmental context

  • Digital image analysis with validated algorithms

• Statistical approach selection:

• Normalization strategies:

  • Identification of stable reference proteins across conditions

  • Total protein normalization methods (REVERT, Ponceau)

  • Tissue-specific and developmental stage-specific reference genes

Similar to approaches used in panel data experimental design, proper statistical power calculations are essential for designing well-powered experiments .

How can researchers effectively troubleshoot inconsistent zgc:110179 antibody performance?

Systematic troubleshooting should follow this structured approach:

• Antibody factors:

  • Storage conditions (aliquoting, temperature, freeze-thaw cycles)

  • Lot-to-lot variation (parallel testing of different lots)

  • Antibody concentration and integrity verification

• Sample preparation variables:

  • Fixation protocol standardization (time, temperature, buffer composition)

  • Antigen retrieval optimization (pH, time, temperature)

  • Developmental staging accuracy and consistency

• Protocol optimization:

• Environmental and handling factors:

  • Temperature and humidity monitoring during incubations

  • Light exposure minimization for fluorescent detection methods

  • Consistent handling practices across experiments

Systematic documentation of all parameters across experiments facilitates identification of critical variables affecting antibody performance.

What cutting-edge imaging and analysis approaches can maximize information obtained with zgc:110179 antibodies?

Advanced imaging technologies enable deeper insights into protein localization and dynamics:

• Super-resolution microscopy options:

  • Stimulated Emission Depletion (STED) microscopy (70-90nm resolution)

  • Photoactivated Localization Microscopy (PALM) (20-30nm resolution)

  • Structured Illumination Microscopy (SIM) (100-120nm resolution)

• Live imaging approaches:

  • Light sheet fluorescence microscopy for whole-embryo imaging

  • Spinning disk confocal for rapid acquisition and reduced phototoxicity

  • Two-photon microscopy for deep tissue penetration

• Advanced computational analysis:

  • Machine learning-based segmentation for automated quantification

  • 3D reconstruction and rendering for volumetric analysis

  • Colocalization analysis with proper statistical testing

• Multiplexed imaging strategies:

  • Sequential imaging with antibody stripping/reprobing

  • Spectral unmixing for simultaneous multi-protein detection

  • Mass cytometry (CyTOF) or imaging mass cytometry for highly multiplexed analysis

These approaches can be combined with genetic manipulation strategies to provide functional context to protein localization observations.

How can researchers integrate zgc:110179 antibody studies with broader systems biology approaches?

Integrated research strategies place protein expression in wider biological context:

• Multi-omics integration:

  • Correlation with transcriptomics data (RNA-seq, microarray)

  • Integration with proteomics datasets (mass spectrometry)

  • Network analysis with interactome data

• Functional genomics approaches:

  • CRISPR screens to identify genetic interactors

  • Chemical genetics to probe pathway relationships

  • Suppressors/enhancers screening in genetic backgrounds

• Evolutionary analysis:

  • Cross-species antibody reactivity testing

  • Comparative expression studies across related species

  • Structure-function analysis of conserved domains

• Pathway analysis:

  • Perturbation studies with specific pathway inhibitors

  • Epistasis experiments to establish pathway position

  • Mathematical modeling of pathway dynamics

Similar to approaches used in the study of protective antibody responses against Zika virus, longitudinal sampling and next-generation sequencing analysis can provide insights into developmental regulation and functional roles .

What considerations are important when designing zgc:110179 antibody studies in genetic manipulation contexts?

Genetic manipulation introduces additional experimental variables:

• Knockout/knockdown validation:

  • Verification of complete protein loss in null mutants

  • Quantification of knockdown efficiency in morphants/CRISPants

  • Monitoring for compensatory mechanisms

• Tagged protein considerations:

  • Verification that tags don't interfere with protein function

  • Comparison of tagged protein localization with antibody staining

  • Assessment of expression levels relative to endogenous protein

• Rescue experiment design:

  • Titration of rescue construct expression levels

  • Temporal control of rescue expression

  • Domain-specific mutations to assess structure-function relationships

• Experimental controls for genetic studies:

Combining antibody detection with these genetic approaches provides powerful tools for understanding protein function in developmental contexts.